Health-related quality of life among breast cancer patients in India
- 12 October 2022
- journal article
- research article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 30 (12) , 9983-9990
Abstract
Purpose This study evaluated the health-related quality of life (HRQoL) among breast cancer patients during various phases of treatment and with different treatment modalities, which helps in monitoring treatment outcomes, assessing the well-being of patients, and conducting health technology assessments. Methods A total of 534 interviews were conducted among the patients of breast cancer recruited at different stages of disease and with different treatment modalities. HRQoL was determined using EuroQoL five dimensions questionnaire with five levels (EQ-5D-5L), EuroQoL Visual Analogue Scale (EQ VAS), and the EORTC QLQ-BR23 instrument. The utility values were determined based on the Indian EQ-5D-5L value set. The socio-demographic and clinico-therapeutic determinants of HRQoL were evaluated using multiple linear regression. Results The mean utility value of breast cancer patients was 0.602 (SD = 0.311) and mean EQ VAS score was 75 (SD = 12.3). The mean utility value at diagnosis was 0.628, whereas utility value was 0.55, 0.595, and 0.64 for post-surgery, post-chemotherapy, and post-radiotherapy treatment groups, respectively. The most frequently reported problem was pain/discomfort (in 84.3% patients), followed by anxiety/depression (83.5%). On EORTC QLQ-BR23, the maximum symptom scale scores for systemic therapy side effects were reported in the post chemotherapy group. The body image score and future perspective score were better in patients undergoing breast conservative surgery (BCS) compared to patients undergoing modified radical mastectomy. Age, education, and employment status of the patient, type of treatment modality, and use of taxanes are the determinants of HRQoL in breast cancer patients. Conclusion Clinical interventions should focus upon management of pain and anxiety. BCS should be offered to all eligible patients as it is associated with better HRQoL. Addressing the factors that independently affect the HRQoL will help in improving the treatment compliance and outcomes.Keywords
Funding Information
- Department of Science & Technology & Renewable Energy, Chandigarh Administration (S&T&RE/RP/147/(19-20)/Sanc/10/2019/1703-1710)
This publication has 27 references indexed in Scilit:
- Breast cancer: An overview of published Indian dataSouth Asian Journal of Cancer, 2016
- Health-related quality of life among patients with advanced cancer: an integrative reviewRevista da Escola de Enfermagem da USP, 2014
- Patient age is related to decision-making, treatment selection, and perceived quality of life in breast cancer survivorsWorld Journal of Surgical Oncology, 2014
- Heath-related quality of life in Spanish breast cancer patients: a systematic reviewHealth and Quality of Life Outcomes, 2011
- Quality of life among young women with breast cancer: Study from a tertiary cancer institute in south IndiaIndian Journal of Cancer, 2010
- Quality of Life of African American Breast Cancer SurvivorsCancer Nursing, 2008
- Quality of life over 5 years in women with breast cancer after breast-conserving therapy versus mastectomy: a population-based studyJournal of Cancer Research and Clinical Oncology, 2008
- Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapyBreast Cancer Research and Treatment, 2006
- EQ-SD: a measure of health status from the EuroQol GroupAnnals of Medicine, 2001
- The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study.Journal of Clinical Oncology, 1996